News + Filings Transactions Holdings
All 13F 13D/G Other
|
Nantahala Capital Management, LLC
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/14/2023 |
SC 13G
| Nantahala Capital Management, LLC reports a 7.9% stake in ABEONA THERAPEUTICS INC |
02/14/2023 |
SC 13G
| Nantahala Capital Management, LLC reports a 5.1% stake in BIOVENTUS INC. |
02/14/2023 |
SC 13G
| Nantahala Capital Management, LLC reports a 7% stake in Drive Shack Inc. |
02/14/2023 |
SC 13G
| Nantahala Capital Management, LLC reports a 7% stake in Lyra Therapeutics, Inc. |
12/28/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/14/2022 |
SC 13G
| Nantahala Capital Management, LLC reports a 5.6% stake in Autolus Therapeutics plc |
02/14/2022 |
SC 13G
| Nantahala Capital Management, LLC reports a 6.2% stake in The RMR Group Inc. |
02/14/2022 |
SC 13G
| Nantahala Capital Management, LLC reports a 5.1% stake in FINTECH ACQUISITION CORP. V |
02/14/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/14/2022 |
SC 13G
| Nantahala Capital Management, LLC reports a 8% stake in UNICYCIVE THERAPEUTICS, INC. |
02/14/2022 |
SC 13G
| Nantahala Capital Management, LLC reports a 5.8% stake in Syndax Pharmaceuticals, Inc. |
02/14/2022 |
SC 13G
| Nantahala Capital Management, LLC reports a 6.2% stake in Immatics N.V. |
02/14/2022 |
SC 13G
| Nantahala Capital Management, LLC reports a 8.8% stake in IMAX Corporation |
02/14/2022 |
SC 13G
| Nantahala Capital Management, LLC reports a 9.9% stake in IDW Media Holdings, Inc. |
02/14/2022 |
SC 13G
| Nantahala Capital Management, LLC reports a 6.5% stake in ARYA SCIENCES ACQUISITION CORP V |
02/14/2022 |
SC 13G
| Nantahala Capital Management, LLC reports a 7.6% stake in RED VIOLET, INC. |
02/14/2022 |
SC 13G
| Nantahala Capital Management, LLC reports a 7.7% stake in Avenue Therapeutics, Inc. |
02/14/2022 |
SC 13G
| Nantahala Capital Management, LLC reports a 9.5% stake in BBQ HOLDINGS, INC. |
02/14/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/14/2022 |
SC 13G
| Nantahala Capital Management, LLC reports a 5.1% stake in INSU ACQUISITION CORP. III |
02/14/2022 |
SC 13G
| Nantahala Capital Management, LLC reports a 5.7% stake in AEGLEA BIOTHERAPEUTICS, INC. |
04/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/16/2021 |
SC 13G
| Nantahala Capital Management, LLC reports a 6.9% stake in WAVE LIFE SCIENCES LTD. |
02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/16/2021 |
SC 13G
| Nantahala Capital Management, LLC reports a 5.4% stake in SEMLER SCIENTIFIC, INC. |
02/16/2021 |
SC 13G
| Nantahala Capital Management, LLC reports a 7.2% stake in METROMILE, INC. |
02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/16/2021 |
SC 13G
| Nantahala Capital Management, LLC reports a 5.1% stake in FINTECH ACQUISITION CORP. IV |
02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/16/2021 |
SC 13G
| Nantahala Capital Management, LLC reports a 7.5% stake in SELECT INTERIOR CONCEPTS, INC. |
02/16/2021 |
SC 13G
| Nantahala Capital Management, LLC reports a 9% stake in GALMED PHARMACEUTICALS LTD. |
|
|
|